0

524314

GUJTERC

img img img img
No Data Available

GUJARAT TERCE LABORATORIES LTD Share Price Update

As of the latest trading session, GUJARAT TERCE LABORATORIES LTD share price is currently at ₹37.8, which is down by ₹-1.09 from its previous closing. Today, the stock has fluctuated between ₹37.22 and ₹41.35. Over the past year, GUJARAT TERCE LABORATORIES LTD has achieved a return of -36.75%. In the last month alone, the return has been 1.01%.

Investment Returns

Over 1 Month [-]% Over 3 Months [-]% Over 6 Months [-]% Over 1 Year [-]%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

GUJARAT TERCE LABORATORIES LTD fundamentals


  • Market cap (Cr)

    [-]

  • P/E Ratio (TTM)

    [-]

  • Beta

    [-]

  • Book Value / share

    [-]

  • Return on equity

    [-]%

  • EPS (TTM)

    [-]

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    [-]

info icon alternate text
  • Market cap (Cr)

    29.50

  • P/E Ratio (TTM)

    -23.86

  • Beta

    0.57

  • Book Value / share

    11.40

  • Return on equity

    0.00%

  • EPS (TTM)

    0.00

  • Dividend yield

    [-]%

  • Net profit/quarter (Cr)

    0.76

info icon alternate text

GUJARAT TERCE LABORATORIES LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2025 (Values in Cr)
Revenue 12.29
Operating Expense 11.29
Net Profit 0.76
Net Profit Margin (%) 6.18
Earnings Per Share (EPS) 0.95
EBITDA 1.27
Effective Tax Rate (%) 32.74
Particulars SEP 2025 (Values in Cr)
Revenue 12.93
Operating Expense 11.20
Net Profit 1.40
Net Profit Margin (%) 10.82
Earnings Per Share (EPS) 1.89
EBITDA 1.95
Effective Tax Rate (%) 21.34
Particulars JUN 2025 (Values in Cr)
Revenue 10.85
Operating Expense 11.02
Net Profit -0.04
Net Profit Margin (%) -0.36
Earnings Per Share (EPS) -0.06
EBITDA 0.08
Effective Tax Rate (%) 42.85
Particulars MAR 2025 (Values in Cr)
Revenue 12.32
Operating Expense 11.44
Net Profit -3.39
Net Profit Margin (%) -27.51
Earnings Per Share (EPS) -4.57
EBITDA 1.14
Effective Tax Rate (%) 449.48
Particulars DEC 2024 (Values in Cr)
Revenue 12.68
Operating Expense 11.77
Net Profit 1.01
Net Profit Margin (%) 7.96
Earnings Per Share (EPS) 1.36
EBITDA 1.16
Effective Tax Rate (%) -3.06
Particulars MAR 2025 (Values in Cr)
Revenue 50.20
Operating Expense 47.12
Net Profit -0.98
Net Profit Margin (%) -1.95
Earnings Per Share (EPS) -1.31
EBITDA 4.19
Effective Tax Rate (%) 128.90
Particulars MAR 2024 (Values in Cr)
Revenue 47.97
Operating Expense 47.76
Net Profit 0.24
Net Profit Margin (%) 0.50
Earnings Per Share (EPS) 0.33
EBITDA 1.59
Effective Tax Rate (%) 55.55
Particulars MAR 2023 (Values in Cr)
Revenue 46.78
Operating Expense 50.03
Net Profit -1.67
Net Profit Margin (%) -3.56
Earnings Per Share (EPS) -2.25
EBITDA -1.81
Effective Tax Rate (%) 42.21
Particulars MAR 2022 (Values in Cr)
Revenue 40.13
Operating Expense 39.69
Net Profit 0.87
Net Profit Margin (%) 2.16
Earnings Per Share (EPS) 1.18
EBITDA 1.43
Effective Tax Rate (%) -17.33
Particulars MAR 2021 (Values in Cr)
Revenue 25.18
Operating Expense 28.51
Net Profit -2.52
Net Profit Margin (%) -10.00
Earnings Per Share (EPS) -3.40
EBITDA -1.95
Effective Tax Rate (%) 0.39
Particulars MAR 2025 (Values in Cr)
Book Value / Share 8.26
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.35
EBITDA Margin 8.37
Particulars MAR 2024 (Values in Cr)
Book Value / Share 9.58
ROE % 2.96
ROCE % 7.17
Total Debt to Total Equity 0.80
EBITDA Margin 3.31
Particulars MAR 2023 (Values in Cr)
Book Value / Share 9.25
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.91
EBITDA Margin -3.87
Particulars MAR 2022 (Values in Cr)
Book Value / Share 11.50
ROE % 10.24
ROCE % 6.74
Total Debt to Total Equity 0.70
EBITDA Margin 3.54
Particulars MAR 2021 (Values in Cr)
Book Value / Share 10.33
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.39
EBITDA Margin -7.82
Particulars MAR 2025 (Values in Cr)
Cash & Short Term Investments 0.77
Total Assets 22.82
Total Liabilities 22.82
Total Equity 6.47
Share Outstanding 0
Price to Book Ratio 7.40
Return on Assets (%) -4.28
Return on Capital (%) -13.19
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.09
Total Assets 23.27
Total Liabilities 23.27
Total Equity 7.10
Share Outstanding 0
Price to Book Ratio 5.53
Return on Assets (%) 1.04
Return on Capital (%) 2.22
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 2.02
Total Assets 28.52
Total Liabilities 28.52
Total Equity 6.86
Share Outstanding 0
Price to Book Ratio 1.80
Return on Assets (%) -5.85
Return on Capital (%) -11.83
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 27.39
Total Liabilities 27.39
Total Equity 8.53
Share Outstanding 0
Price to Book Ratio 2.27
Return on Assets (%) 3.18
Return on Capital (%) 5.74
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 1.28
Total Assets 21.87
Total Liabilities 21.87
Total Equity 7.66
Share Outstanding 0
Price to Book Ratio 0.67
Return on Assets (%) -11.52
Return on Capital (%) -20.33
Particulars MAR 2025 (Values in Cr)
Net Income 3.39
Cash from Operations 3.14
Cash from Investing 0.45
Cash from Financing -2.82
Net change in Cash 0.68
Free Cash Flow 3.14
Particulars MAR 2024 (Values in Cr)
Net Income 0.54
Cash from Operations 2.59
Cash from Investing -0.45
Cash from Financing -4.08
Net change in Cash -1.93
Free Cash Flow 2.67
Particulars MAR 2023 (Values in Cr)
Net Income -2.89
Cash from Operations 0.06
Cash from Investing 0.61
Cash from Financing -0.12
Net change in Cash 0.52
Free Cash Flow 0.12
Particulars MAR 2022 (Values in Cr)
Net Income 0.74
Cash from Operations -0.34
Cash from Investing -0.86
Cash from Financing 1.53
Net change in Cash 0.22
Free Cash Flow 1.77
Particulars MAR 2021 (Values in Cr)
Net Income -2.52
Cash from Operations -0.01
Cash from Investing -0.42
Cash from Financing 1.83
Net change in Cash 1.24
Free Cash Flow 0.48
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.21 14.38 1.72 254.50 23.12 41.45
BLISS GVS PHARMA LTD. 273.75 26.17 2.55 2895.97 105.05 277.05
CIPLA LTD 1235.00 20.98 3.03 99761.15 1165.55 1672.20
FERMENTA BIOTECH LIMITED 315.25 10.49 2.37 927.81 252.15 399.00
GLAXOSMITHKLINE PHARMA LT 2462.75 41.48 24.43 41720.47 2218.00 3515.95
Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
AMBALAL SARABHAI ENT L 33.21 31.93 4.62 254.50 23.12 41.45
AMRUTAJAN HEALTH LTD 571.50 28.58 4.83 1652.24 490.00 789.95
ASTRAZENECA PHARMA INDIA LTD. 8443.20 101.47 26.41 21108.00 7630.00 10653.05
BLISS GVS PHARMA LTD. 273.75 37.30 2.62 2895.97 105.05 277.05

GUJARAT TERCE LABORATORIES LTD shareholding pattern

Holding

59.97%
40.02%
Name Shares Category
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)
(%)

GUJARAT TERCE LABORATORIES LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
37.80 -2.80 redarrow
red-green-graph indicator
6 Bearish
10 Bullish
  • 5 Days 37.80
  • 26 Days 36.10
  • 10 Days 36.40
  • 50 Days 37.70
  • 12 Days 36.10
  • 100 Days 40.50
  • 20 Days 35.90
  • 200 Days 44.70
39.55 PIVOT

First Support

37.09

First Resistance

41.34

Second Support

35.30

Second Resistance

43.80

Third Support

32.84

Third Resistance

45.59

RSI

58.64

ADX

31.03

MACD

0.01

Williams % R

-27.07

Commodity Channel Index (CCI)

125.63

Date

2026-04-22

Week

14557.00

Same Day

10224.00

Month

10462.00

1 Year

0.58

3 Year

0.19

Over 1 Month

1.01%

down

Over 1 Year

-36.75%

down

Over 3 Months

-10.65%

down

Over 3 Years

22.41%

down

Over 6 Months

-26.31%

down

Over 5 Years

40.47%

down

GUJARAT TERCE LABORATORIES LTD Corporate Actions

Top Gainers

GUJARAT TERCE LABORATORIES LTD Share Price

Gujarat Terce Laboratories Limited, incorporated in 1985, is a trusted manufacturer of high quality medication at affordable rates for the common man. Company specialise in producing oral solid dosages, including tablets and capsules, that address various therapeutic needs.
Headquartered in Ahmedabad, Gujarat, Terce offers an extensive portfolio featuring over 125 products and more than 64 well-established brands.

By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing. In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange. In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat. As India heralded new leaps in the pharma sector to become a global force to reckon with by 2005, the Company closely followed the narrative with ferocious growth expanding presence in the domestic and international market.

The Company offers products in the form of tablets, capsules, syrups, and injections. The installed capacity of the Company is 270 million tablets and 108 million capsules per annum. It focuses on formulation improvements, new product development, and research to identify gaps in existing treatment options.

The Company otherwise or hence maintains strict and controlled environment for manufacturing and adheres to Good Manufacturing Practices and Good Laboratory Practices to assure highest level of patient safety and outcome efficacy. It has well-defined Total Quality Management System in place to continuously optimize products and processes. Each process is thoroughly monitored and data is collected for analysis which helps in planning corrective and preventive strategies for quality control.

To serve the needs of patients and healthcare professionals, Company focus on early and rapid detection of diseases. Their team of scientists is supported by doctors, patients and marketing team in identifying pressing needs and developing solutions. It has capabilities of innovation across generic drugs to complex formulations, biosimilars and new molecular entity.

Parent organization Indian Private
NSE symbol [-]
Founded 1985
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Gujarat Terce Laboratories Ltd?

Answer Field

Gujarat Terce Laboratories Ltd share price is for NSE ₹ 0.00 & for BSE ₹ 37.80 as on Apr 23 2026 03:29 PM.

What is the Market Cap of Gujarat Terce Laboratories Ltd Share?

Answer Field

The market cap of Gujarat Terce Laboratories Ltd for NSE ₹ 0.00 & for BSE ₹ 29.50 as on Apr 23 2026 03:29 PM.

What is the 52 Week High and Low of Gujarat Terce Laboratories Ltd?

Answer Field

The 52 Week High and Low of Gujarat Terce Laboratories Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 68.40 and ₹ 29.00.

What is 1 year return for Gujarat Terce Laboratories Ltd?

Answer Field

The 1 year returns on the stock has been -36.75%.

What is the P/E Ratio of Gujarat Terce Laboratories Ltd Share?

Answer Field

As on Apr 23 2026 03:29 PM the price-to-earnings (PE) ratio for Gujarat Terce Laboratories Ltd share is -23.86.

What is the PB ratio of Gujarat Terce Laboratories Ltd Share?

Answer Field

As on Apr 23 2026 03:29 PM, the price-to-book (PB) ratio for Gujarat Terce Laboratories Ltd share is 11.40.

How to Buy Gujarat Terce Laboratories Ltd Share?

Answer Field

You can trade in Gujarat Terce Laboratories Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Gujarat Terce Laboratories Ltd Share on Bajaj Broking App?

Answer Field

To buy Gujarat Terce Laboratories Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Gujarat Terce Laboratories Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

close-image

Get Free Demat Account*

+91
close-img

Authorise with OTP

Enter the 4-Digit OTP sent to
edit
OTP expires in 00:59
banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|